From: Enhanced recovery after surgery (ERAS) program for lumbar spine fusion
Pre-ERAS (n = 123) | Post-ERAS (n = 96) | *p value | |
---|---|---|---|
Patient contacted 1 day after discharge | 4 (3.3%) | 9 (9.4%) | 0.0803 |
Pain at postoperative wound visit (NPRS) | 45.6 (25.3) | 48.9 (26.0) | 0.3575 |
Medications used at postoperative wound visit | |||
• NSAIDs | 32 (26.0%) | 24 (25.0%) | 0.8728 |
• Opioids, short-acting (immediate-release) | 100 (81.3%) | 80 (83.3%) | 0.7247 |
• Opioids, long-acting (extended-release, e.g., OxyContin, MSContin, Methadone) | 18 (14.6%) | 5 (5.2%) | 0.0253 |
• Anticonvulsants | 27 (22.0%) | 64 (66.7%) | < .0001 |
• Antidepressants | 25 (20.3%) | 22 (22.9%) | 0.7416 |
• Benzodiazepines | 27 (22.0%) | 23 (24.0%) | 0.7449 |
• Muscle relaxants | 97 (78.9%) | 63 (65.6%) | 0.0348 |
• Acetaminophen | 49 (39.8%) | 48 (50.0%) | 0.1675 |
Signs of infection present | 2 (1.6%) | 2 (2.1%) | 1.0000 |